Cargando…
Primary ovarian insufficiency: different approaches in three cases and a review of literature
Primary ovarian insufficiency (POI) is the condition of intermittent or permanent gonadal insufficiency that occurs in women before the age of 40. We describe three cases of POI referred to the outpatient endocrinology clinic of a university hospital. The three patients met diagnostic criteria for P...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888608/ https://www.ncbi.nlm.nih.gov/pubmed/27252868 http://dx.doi.org/10.1530/EDM-16-0026 |
_version_ | 1782434872011259904 |
---|---|
author | Moreira, Ana Marina Spritzer, Poli Mara |
author_facet | Moreira, Ana Marina Spritzer, Poli Mara |
author_sort | Moreira, Ana Marina |
collection | PubMed |
description | Primary ovarian insufficiency (POI) is the condition of intermittent or permanent gonadal insufficiency that occurs in women before the age of 40. We describe three cases of POI referred to the outpatient endocrinology clinic of a university hospital. The three patients met diagnostic criteria for POI and were managed by specific approaches tailored to individualized goals. In the first case, the main concern was fertility and the reproductive prognosis. The second patient was a carrier of a common genetic cause of POI: premutation of the FMR1 gene. The third case was a patient diagnosed with a POI and established osteoporosis, a common complication of estrogen deprivation. This study reports the treatment and follow-up of these cases, with an emphasis on relevant aspects of individualized management, alongside a brief literature review. LEARNING POINTS: A diagnosis of POI should be considered in patients presenting with amenorrhea or irregular menses and high serum follicle-stimulating hormone (FSH) levels before age 40 years. Patients with POI without an established cause, especially in familial cases, should be tested for FMR1 mutations. Estrogen/progestin replacement therapy is indicated since diagnosis until at least the estimated age of menopause, and is the cornerstone for maintaining the good health of breast and urogenital tract and for primary or secondary osteoporosis prevention in POI. Fertility should be managed through an individualized approach based on patient possibilities, such as egg or embryo donation and ovarian cryopreservation; pregnancy can occur spontaneously in a minority of cases. Women with POI should be carefully monitored for cardiovascular risk factors. |
format | Online Article Text |
id | pubmed-4888608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-48886082016-06-01 Primary ovarian insufficiency: different approaches in three cases and a review of literature Moreira, Ana Marina Spritzer, Poli Mara Endocrinol Diabetes Metab Case Rep Insight into Disease Pathogenesis or Mechanism of Therapy Primary ovarian insufficiency (POI) is the condition of intermittent or permanent gonadal insufficiency that occurs in women before the age of 40. We describe three cases of POI referred to the outpatient endocrinology clinic of a university hospital. The three patients met diagnostic criteria for POI and were managed by specific approaches tailored to individualized goals. In the first case, the main concern was fertility and the reproductive prognosis. The second patient was a carrier of a common genetic cause of POI: premutation of the FMR1 gene. The third case was a patient diagnosed with a POI and established osteoporosis, a common complication of estrogen deprivation. This study reports the treatment and follow-up of these cases, with an emphasis on relevant aspects of individualized management, alongside a brief literature review. LEARNING POINTS: A diagnosis of POI should be considered in patients presenting with amenorrhea or irregular menses and high serum follicle-stimulating hormone (FSH) levels before age 40 years. Patients with POI without an established cause, especially in familial cases, should be tested for FMR1 mutations. Estrogen/progestin replacement therapy is indicated since diagnosis until at least the estimated age of menopause, and is the cornerstone for maintaining the good health of breast and urogenital tract and for primary or secondary osteoporosis prevention in POI. Fertility should be managed through an individualized approach based on patient possibilities, such as egg or embryo donation and ovarian cryopreservation; pregnancy can occur spontaneously in a minority of cases. Women with POI should be carefully monitored for cardiovascular risk factors. Bioscientifica Ltd 2016-05-27 2016 /pmc/articles/PMC4888608/ /pubmed/27252868 http://dx.doi.org/10.1530/EDM-16-0026 Text en © 2016 The authors This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en_GB) . |
spellingShingle | Insight into Disease Pathogenesis or Mechanism of Therapy Moreira, Ana Marina Spritzer, Poli Mara Primary ovarian insufficiency: different approaches in three cases and a review of literature |
title | Primary ovarian insufficiency: different approaches in three cases and a review of literature |
title_full | Primary ovarian insufficiency: different approaches in three cases and a review of literature |
title_fullStr | Primary ovarian insufficiency: different approaches in three cases and a review of literature |
title_full_unstemmed | Primary ovarian insufficiency: different approaches in three cases and a review of literature |
title_short | Primary ovarian insufficiency: different approaches in three cases and a review of literature |
title_sort | primary ovarian insufficiency: different approaches in three cases and a review of literature |
topic | Insight into Disease Pathogenesis or Mechanism of Therapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888608/ https://www.ncbi.nlm.nih.gov/pubmed/27252868 http://dx.doi.org/10.1530/EDM-16-0026 |
work_keys_str_mv | AT moreiraanamarina primaryovarianinsufficiencydifferentapproachesinthreecasesandareviewofliterature AT spritzerpolimara primaryovarianinsufficiencydifferentapproachesinthreecasesandareviewofliterature |